Trv Gp II, LLC
10% owner at RVMD; 10% owner at Jounce Therapeutics, Inc.
- Sold, on record
- $46.3M
- Dollars the filings state
- Form 4 sales
- 3
- Latest May 26, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- RVMDRevolution Medicines, Inc.10% owner
- Jounce Therapeutics, Inc.10% owner
Sales by reason
0
Routine
2
Plan not stated
0
No plan
1
Unusual
Form 4 sales per year, every sale on record.
Sales by company
- RVMD1.4M shares
- Jounce Therapeutics, Inc.567,520 shares
Shares sold, every Form 4 sale on record.
Timeline
- May 26, 2021Unusual
Sold 71.6% of their holdings
$41.8M1.4M shares at $30.57
- May 25, 2021Plan not stated
Sold 8.5% of their holdings
$4.4M552,520 shares at $8.00
- Nov 17, 2020Plan not stated
Sold 0.2% of their holdings
$109k15,000 shares at $7.25
3 of 3
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| May 26, 2021 | May 27, 2021 | RVMD | 10% owner | Sold | 1.4M | $30.57 | $41.8M | 543,113 | SEC |
| May 25, 2021 | May 27, 2021 | Jounce Therapeutics, Inc. | 10% owner | Sold | 552,520 | $8.00 | $4.4M | 5.9M | SEC |
| Nov 17, 2020 | Nov 19, 2020 | Jounce Therapeutics, Inc. | 10% owner | Sold | 15,000 | $7.25 | $109k | 9.2M | SEC |
| May 17, 2017 | May 19, 2017 | Global Blood Therapeutics, Inc. | 10% owner | Other | 1M | 3.5M | SEC | ||
| Apr 18, 2017 | May 19, 2017 | Global Blood Therapeutics, Inc. | 10% owner | Gift | 51,708 | 163,996 | SEC | ||
| Mar 30, 2017 | Apr 3, 2017 | MyoKardia Inc | 10% owner | Other | 850,000 | 7.7M | SEC | ||
| Nov 18, 2015 | Nov 18, 2015 | BPMC | 10% owner | Other | 1.3M | 40,290 | SEC | ||
| Jun 19, 2015 | Jun 22, 2015 | Sage Therapeutics, Inc. | 10% owner | Other | 1.1M | 27,331 | SEC |
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 26, 2021 | May 27, 2021 | RVMD | 10% owner | Form 4 sale | 1.4M | $41.8M | 71.6% | Unusual | SEC |
| May 25, 2021 | May 27, 2021 | Jounce Therapeutics, Inc. | 10% owner | Form 4 sale | 552,520 | $4.4M | 8.5% | Plan not stated | SEC |
| Nov 17, 2020 | Nov 19, 2020 | Jounce Therapeutics, Inc. | 10% owner | Form 4 sale | 15,000 | $109k | 0.2% | Plan not stated | SEC |